CALA Shariah Compliance
Screening Methodology: AAOIFI
NOT HALAL
Last Updated: April 05, 2023
Report Source: 2022 Annual Report
Calithera Biosciences Inc. Stock Analysis CALA
Calithera Biosciences, Inc. is a clinical stage precision oncology biopharmaceutical company, which engages in developing targeted therapies to redefine treatment for biomarker-specific patient populations. The firm is winding up its operations. The firm is seeking to sell all of its clinical assets and programs. The firm has not generated any revenue.
Read More Calithera Biosciences Inc (CALA) Chart
Key Statistics of Calithera Biosciences Inc (CALA)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$0.00Volume
3667.00P/E Ratio (TTM)
-52 Week Range
Market Cap
1462.00Avg. Volume
1347.14Dividend Yield
-Financial Metrics & Statements of Calithera Biosciences Inc (CALA)
FAQ's for Calithera Biosciences Inc (CALA)
- According to Musaffa’s Shariah screening methodology, Calithera Biosciences Inc (CALA) is currently classified as NOT HALAL as of April 2023. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.